FOXO Health
Systems Health Dashboard
Anonymous Member
32M ยท Bengaluru
System Status
6Strained
3Compensating
๐Ÿงฌ

Metabolic

Metabolism + Mitochondria

StrainedProtocol: Correct
๐Ÿ”ฌ

Key Insights

A. Insulin Resistance Is Established and Progressing
โ—Fasting Insulin 6.15 ยตIU/mL (Suboptimal; optimal 4.6-5.5) - the pancreas is overproducing insulin to maintain glucose control.
โ—FBS 86.63 mg/dL (Suboptimal; optimal 75-86) - hepatic glucose output exceeds functional optimal despite compensatory insulin.
โ—Fructosamine 236.69 ยตmol/L (Suboptimal; optimal 190-228) - confirms this is a chronic pattern over the preceding 2-3 weeks, not a one-off reading.
โ—TG/HDL ratio 2.26 (Suboptimal; optimal 0.50-1.90) - the strongest surrogate marker of insulin resistance and small-dense LDL presence.
B. Metabolic Inflexibility Confirmed by Metabolomics
โ—D3HB (blood ketone) 0.35 mmol/L (Suboptimal; optimal 1.08-1.94) - ketogenesis profoundly suppressed even fasting, confirming the body cannot switch to fat oxidation efficiently.
โ—Urinary Citrate 6.97 (High Risk; optimal 0-4.12) - TCA cycle bottleneck with citrate accumulation, indicating mitochondrial throughput strain.
โ—Urinary Succinate 2.36 (Suboptimal; optimal 0.03-2.68) - Complex II strain, consistent with NAD+ depletion from B3 0.62 ยตg/L (Suboptimal).
C. Thyroid Dysfunction Amplifies Metabolic Inefficiency
โ—TSH 8.72 mIU/L (High Risk; optimal 1.88-3.41) with T4 6.26 ยตg/dL (Optimal but at floor) - the thyroid is being driven maximally but producing minimally adequate hormone.
โ—Thyroid regulates mitochondrial biogenesis, fat oxidation rate, and lipid clearance - its underperformance multiplies insulin resistance effects.
D. Lipid Dysfunction Reflects Metabolic Origin
โ—HDL 40 mg/dL (Suboptimal; optimal 50-90) and Apo-A1 109 mg/dL (Suboptimal; optimal 150-210) - anti-atherogenic lipid transport suppressed.
โ—VLDL 18.18 mg/dL (Suboptimal; optimal 0-15) - hepatic lipogenesis from carbohydrate excess. Lp(a) 25.4 nmol/L (Suboptimal) - permanent genetic cardiovascular risk modifier.
System Mechanism
TCA Cycleโš  backed upB3 / NAD+ depletedAcetyl-CoAentryCitrateโ†‘ High RiskSuccinateโ†‘ SuboptimalMalateOAA
๐Ÿž Glucose (sugar)
Overused ยท ~85% of energy
Insulin resistance locking in glucose dependency
๐Ÿ”ฅ Fat (ketones)
D3HB 0.35 mmol/L ยท optimal 1.08-1.94
Fat oxidation nearly absent even during fasting
๐Ÿ”—

Root Cause Analysis

Each row is a causal chain โ€” blue = root input ยท amber = intermediate ยท red = outcome

Thyroid underperformance (TSH 8.72 High Risk)
โ†’
reduced metabolic rate
โ†’
impaired fat oxidation
โ†’
insulin resistance amplification
Insulin resistance (Insulin 6.15 Suboptimal, Fructosamine 236.69 Suboptimal)
โ†’
hepatic lipogenesis
โ†’
VLDL 18.18 Suboptimal
โ†’
HDL suppression
โ†’
atherogenic profile
NAD+ depletion (B3 0.62 Suboptimal)
โ†’
TCA cycle bottleneck (Citrate 6.97 High Risk, Succinate 2.36 Suboptimal)
โ†’
mitochondrial strain
โ†’
energy variability and fatigue
Sedentary lifestyle + refined carb-dominant diet
โ†’
glucose bias
โ†’
ketogenesis suppressed (D3HB 0.35 Suboptimal)
โ†’
metabolic inflexibility
Lead 36.3 (Suboptimal)
โ†’
thyroid disruption
โ†’
reduced metabolic rate
โ†’
compounds the metabolic cascade
โš ๏ธ

Clinical Implications

Current State
Post-meal fatigue (daily) โ€” insulin surge driving a reactive hypoglycaemia-like pattern
Sugar/carb cravings (daily) โ€” glucose-dependent brain fuelling
Gradual belly fat gain โ€” visceral adiposity from insulin dominance
Difficulty losing weight despite efforts โ€” metabolic inflexibility
If Uncorrected โ€” 1 to 5 Years
โ†’Progression to frank insulin resistance (HOMA-IR >2.5)
โ†’Fasting glucose rising above 100 mg/dL
โ†’HbA1c crossing into pre-diabetic range (>5.7%)
โ†’NAFLD development - SGPT 26.3 already showing early signal
What this means for you

Your body has largely lost the ability to switch between sugar and fat as fuel - a pattern called metabolic inflexibility. Your thyroid is being pushed very hard but producing minimal output, compounding insulin resistance and slowing every downstream process. At 32, with both parents having T2DM, you are at the critical intervention window where targeted changes carry the highest return.

๐Ÿ”€Cross-System Connectionsโ€” this system's state directly compounds the following